MOESM1 of AGI-134: a fully synthetic α-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models

Autor: Shaw, Stephen, Middleton, Jenny, Wigglesworth, Kim, Charlemagne, Amber, Schulz, Oliver, Glossop, Melanie, Whalen, Giles, Old, Robert, Westby, Mike, Pickford, Chris, Tabakman, Rinat, Carmi-Levy, Irit, Abi Vainstein, Sorani, Ella, Zur, Arik, Kristian, Sascha
Rok vydání: 2019
DOI: 10.6084/m9.figshare.11415693.v1
Popis: Additional file 1: Figure S1. Compound structures. (A) AGI-134 (functional head group is a galactose-α-1,3-galactosyl-beta-1,4-N-acetyl-glucosamine: α-Gal); (B) FSL-Fluorescein (functional group is fluorescein); (C) FSL-A (functional group is N-acetyl-galactosamine-α-1,3-fucosyl-α-1,2-galactose: blood group A antigen).
Databáze: OpenAIRE